Revlimid Maintenance Following Stem Cell Transplant in Multiple Myeloma Patients Appears to Improve Overall Survival
Researchers at Buffalo, New York’s Roswell Park Cancer Institute…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreResearchers at Buffalo, New York’s Roswell Park Cancer Institute…
In a poster presentation at the 2016 ASCO Annual…
The Moffitt Cancer Center has completed a Phase 1…
The European Commission (EC) has granted provisional approval…
An immune-based vaccine created by researchers at Buffalo, New…
Iceni Pharmaceuticals, formerly known as Big DNA Ltd.,…